Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation ConditioningHematopoietic Stem Cell MobilizationTransplantation, HomologousMelphalanCombined Modality TherapyMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsHematologic NeoplasmsGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34CyclophosphamideTreatment OutcomeMyeloablative AgonistsBlood Component RemovalGraft vs Host DiseaseLymphoma, Non-HodgkinRemission InductionEtoposideBusulfanBone Marrow TransplantationThiotepaGraft SurvivalRecurrenceSalvage TherapyHematopoietic Stem CellsCarmustineStem CellsAntineoplastic Agents, AlkylatingDisease-Free SurvivalHodgkin DiseaseCytarabineVincristineAmyloidosisIfosfamideSurvival RateRetrospective StudiesSurvival AnalysisWhole-Body IrradiationCord Blood Stem Cell TransplantationDoxorubicinTransplantation ChimeraCytophagocytosisBone Marrow PurgingTissue DonorsHematopoiesisTime FactorsDexamethasoneNeoplasmsFollow-Up StudiesPrednisoneAntineoplastic AgentsLeukemia, Myeloid, AcuteHistocompatibilityCarboplatinLymphomaHistocompatibility TestingImmunosuppressive AgentsInfectionPrognosisLiver TransplantationPlatelet CountVidarabineLymphoma, T-CellProspective StudiesLeukemiaTransplantation, IsogeneicFeasibility StudiesFatal OutcomeMyelodysplastic SyndromesPOEMS SyndromeMesenchymal Stem Cell TransplantationGraft vs Leukemia EffectRecombinant ProteinsBlood Cell CountCytomegalovirus InfectionsNeoplasm, ResidualCell TransplantationLymphoma, Mantle-CellAntibodies, Monoclonal, Murine-DerivedBlood CellsBlood Transfusion, AutologousKidney TransplantationBone MarrowT-LymphocytesEmbryonic Stem CellsImmunophenotypingAnemia, AplasticPrecursor Cell Lymphoblastic Leukemia-LymphomaPodophyllotoxinBoronic AcidsHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBreast NeoplasmsLymphocyte DepletionPyrazines